ArticleGigaScience2025
Complete end-to-end learning from protein feature representation to protein interactome inference.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- MPLID (Membrane Protein-Lipid Interaction Database): A Large-Scale Experimental Resource of Residue-Level Protein-Lipid Contacts.GigaScience · 2026Article
- NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition.Research (Washington, D.C.) · 2026Article
- Complete end-to-end learning from protein feature representation to protein interactome inference.GigaScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCo-fractionation coupled with mass spectrometry (CF-MS) is a powerful strategy for mapping protein-protein interactions (PPIs) under near-physiological conditions. Despite recent progress, existing analysis pipelines remain constrained by reliance on handcrafted features, sensitivity to experimental noise, and an inherent focus on pairwise interactions, which limit their scalability and generalizability. To address these difficulties, we introduce FREEPII (Feature Representation Enhancement End-to-End Protein Interaction Inference), a unified deep learning framework that integrates CF-MS data with sequence-derived features to learn biologically meaningful protein-level representations for accurate and efficient inference of PPIs and protein complexes.
resultsFREEPII employs a convolutional neural network architecture to learn protein-level representations directly from raw data, enabling feature sharing across interaction pairs and reducing computational complexity. To enhance robustness against CF-MS noise, protein sequences are introduced as auxiliary input to enrich the feature space with complementary biological cues. The supervised protein embeddings further encode network-level context derived from complex annotations, allowing the model to capture higher-order interactions and enhance the expressive power of protein representations. Extensive benchmarking demonstrates that FREEPII consistently outperforms state-of-the-art CF-MS analysis tools, capturing more biologically coherent and discriminative protein features. Cross-dataset evaluations further reveal that integrating multimodal data from diverse experimental contexts substantially improves the generalization and sensitivity of data-driven models, offering a scalable, cross-species strategy for reliable protein interaction inference.
conclusionsFREEPII provides a unified computational framework that integrates CF-MS data and sequence-derived features to learn discriminative and biologically consistent protein representations. By leveraging multimodal inputs through a coherent deep learning architecture, the model achieves accurate and scalable inference of PPIs and protein complexes across species. Its modality-aware design and supervised protein embeddings capture higher-order interaction contexts, ensuring robust generalization and reliable discovery of novel interactions. Overall, FREEPII offers a flexible and extensible foundation for data-driven exploration of protein interaction networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.